{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:43:09Z","timestamp":1787236989347,"version":"build-2736575974"},"reference-count":217,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T00:00:00Z","timestamp":1762041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T00:00:00Z","timestamp":1762041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Military Med Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Venous thromboembolism (VTE) management in adult burn patients has become a crucial focus in China. The intricate nature of VTE necessitates specialized anticoagulation strategies due to the unique challenges posed by burn injuries. To address this pressing issue, the Burn and Trauma Branch of the Chinese Geriatric Medical Association and Critical Care Group of Burn Surgery Branch of the Chinese Medical Association organized a panel of domestic experts in burn surgery, critical care medicine, vascular surgery, nursing, and health statistics and methodology from Chinese hospitals to discuss VTE-related issues in burn injury, the heightened risk factors such as extensive tissue damage and prolonged immobilization, and the delicate balance required in anticoagulation therapy to mitigate bleeding risks. Based on the latest available research evidence as well as the clinical experience of the panel experts, this consensus comprehensively evaluates factors such as generalizability, suitability, and the potential implications for resource allocation. It also appropriately weighs the clinical advantages against possible drawbacks, resulting in the formulation of 21 guideline recommendations.<\/jats:p>\n                  <jats:p>\n                    <jats:italic>Registration<\/jats:italic>\n                    Practice Guideline REgistry for transPAREncy (PREPARE): No. 2023CN656.\n                  <\/jats:p>","DOI":"10.1186\/s40779-025-00653-9","type":"journal-article","created":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:02:10Z","timestamp":1762099330000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Chinese expert consensus on prevention, diagnosis, and management of venous thromboembolism in adult burn patients (2024)"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4688-5604","authenticated-orcid":false,"given":"Feng","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuo","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Min","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Song","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Bin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding-Hong","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Hui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Sheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Hua","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Bing","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Burn and Trauma Branch of the Chinese Geriatric Medical Association, and Critical Care Group of Burn Surgery Branch of the Chinese Medical Association","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","published-online":{"date-parts":[[2025,11,2]]},"reference":[{"issue":"1","key":"653_CR1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jjcc.2021.08.026","volume":"79","author":"Y Yamashita","year":"2022","unstructured":"Yamashita Y, Morimoto T, Kimura T. Venous thromboembolism: recent advancement and future perspective. J Cardiol. 2022;79(1):79\u201389.","journal-title":"J Cardiol"},{"issue":"9","key":"653_CR2","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1161\/CIRCRESAHA.115.306841","volume":"118","author":"AM Wendelboe","year":"2016","unstructured":"Wendelboe AM, Raskob GE. Global burden of thrombosis: epidemiologic aspects. Circ Res. 2016;118(9):1340\u20137.","journal-title":"Circ Res"},{"issue":"4","key":"653_CR3","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41569-022-00787-6","volume":"20","author":"PL Lutsey","year":"2023","unstructured":"Lutsey PL, Zakai NA. Epidemiology and prevention of venous thromboembolism. Nat Rev Cardiol. 2023;20(4):248\u201362.","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"653_CR4","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.chest.2018.10.040","volume":"155","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Lei J, Shao X, Dong F, Wang J, Wang D, et al. Trends in hospitalization and in-hospital mortality from VTE, 2007 to 2016, in China. Chest. 2019;155(2):342\u201353.","journal-title":"Chest"},{"issue":"1","key":"653_CR5","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.chest.2018.09.020","volume":"155","author":"Z Zhai","year":"2019","unstructured":"Zhai Z, Kan Q, Li W, Qin X, Qu J, Shi Y, et al. VTE risk profiles and prophylaxis in medical and surgical inpatients: the identification of Chinese hospitalized patients\u2019 risk profile for venous thromboembolism (DissolVE-2)-a cross-sectional study. Chest. 2019;155(1):114\u201322.","journal-title":"Chest"},{"issue":"1","key":"653_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.23736\/S0392-9590.23.05177-5","volume":"43","author":"AN Nicolaides","year":"2024","unstructured":"Nicolaides AN, Fareed J, Spyropoulos AC, Kakkar RHL, Antignani PL, Avgerinos E, et al. Prevention and management of venous thromboembolism. International consensus statement. Guidelines according to scientific evidence. Int Angiol. 2024;43(1):1\u2013222.","journal-title":"Int Angiol"},{"issue":"2","key":"653_CR7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10654-021-00813-w","volume":"37","author":"CaL Arnesen","year":"2022","unstructured":"Arnesen CaL, Veres K, Horvath-Puho E, Hansen JB, Sorensen HT, Braekkan SK. Estimated lifetime risk of venous thromboembolism in men and women in a Danish nationwide cohort: impact of competing risk of death. Eur J Epidemiol. 2022;37(2):195\u2013203.","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"653_CR8","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.jtha.2025.01.009","volume":"23","author":"C Cox","year":"2025","unstructured":"Cox C, Roberts LN. Basics of diagnosis and treatment of venous thromboembolism. J Thromb Haemost. 2025;23(4):1185\u2013202.","journal-title":"J Thromb Haemost"},{"issue":"Suppl 3","key":"653_CR9","doi-asserted-by":"publisher","first-page":"S276","DOI":"10.21037\/cdt.2017.09.01","volume":"7","author":"J Stone","year":"2017","unstructured":"Stone J, Hangge P, Albadawi H, Wallace A, Shamoun F, Knuttien MG, et al. Deep vein thrombosis: pathogenesis, diagnosis, and medical management. Cardiovasc Diagn Ther. 2017;7(Suppl 3):S276\u201384.","journal-title":"Cardiovasc Diagn Ther"},{"issue":"3","key":"653_CR10","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.3390\/ijerph19031338","volume":"19","author":"A Markiewicz-Gospodarek","year":"2022","unstructured":"Markiewicz-Gospodarek A, Koziol M, Tobiasz M, Baj J, Radzikowska-Buchner E, Przekora A. Burn wound healing: clinical complications, medical care, treatment, and dressing types: the current state of knowledge for clinical practice. Int J Environ Res Public Health. 2022;19(3):1338.","journal-title":"Int J Environ Res Public Health"},{"key":"653_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/burnst\/tkaa047","volume":"9","author":"P Zhang","year":"2021","unstructured":"Zhang P, Zou B, Liou YC, Huang C. The pathogenesis and diagnosis of sepsis post burn injury. Burns Trauma. 2021;9:tkaa047.","journal-title":"Burns Trauma"},{"key":"653_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s41038-017-0076-x","volume":"5","author":"A Clark","year":"2017","unstructured":"Clark A, Imran J, Madni T, Wolf SE. Nutrition and metabolism in burn patients. Burns Trauma. 2017;5:11.","journal-title":"Burns Trauma"},{"issue":"1","key":"653_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.injury.2024.111955","volume":"56","author":"X Yin","year":"2025","unstructured":"Yin X, Huang S, Zhu Z, Ma Q, Wang Y, Liu X, et al. The global, regional, and national burden of burns: an analysis of injury by fire, heat, and hot substances in the global burden of disease study 2019. Injury. 2025;56(1):111955.","journal-title":"Injury"},{"issue":"3","key":"653_CR14","first-page":"176","volume":"32","author":"FY Gao","year":"2016","unstructured":"Gao FY, Xi YF, Zheng MX, Qiao F. Prevalence of deep venous thrombosis in burn patients and its influencing factors. Zhonghua Shao Shang Za Zhi. 2016;32(3):176\u201380.","journal-title":"Zhonghua Shao Shang Za Zhi"},{"issue":"6","key":"653_CR15","first-page":"726","volume":"33","author":"Y Wang","year":"2019","unstructured":"Wang Y, Huang J, Xu X, Chen J, Wu Z, Gao J, et al. Application of standardized venous thromboembolism prevention program in burn patients. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2019;33(6):726\u20139.","journal-title":"Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi"},{"issue":"3","key":"653_CR16","doi-asserted-by":"publisher","first-page":"A12","DOI":"10.7326\/ACPJC-1995-123-3-A12","volume":"123","author":"WS Richardson","year":"1995","unstructured":"Richardson WS, Wilson MC, Nishikawa J, Hayward RS. The well-built clinical question: a key to evidence-based decisions. ACP J Club. 1995;123(3):A12\u20133.","journal-title":"ACP J Club"},{"issue":"7650","key":"653_CR17","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924\u20136.","journal-title":"BMJ"},{"key":"653_CR18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jclinepi.2023.05.010","volume":"159","author":"HJ Schunemann","year":"2023","unstructured":"Schunemann HJ, Brennan S, Akl EA, Hultcrantz M, Alonso-Coello P, Xia J, et al. The development methods of official GRADE articles and requirements for claiming the use of GRADE - a statement by the GRADE guidance group. J Clin Epidemiol. 2023;159:79\u201384.","journal-title":"J Clin Epidemiol"},{"key":"653_CR19","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovic J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.","journal-title":"BMJ"},{"key":"653_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hernan MA, Reeves BC, Savovic J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.","journal-title":"BMJ"},{"key":"653_CR21","volume-title":"WHO handbook for guideline development","author":"World Health O","year":"2014","unstructured":"World Health O. WHO handbook for guideline development. 2nd ed. Geneva: World Health Organization; 2014.","edition":"2"},{"issue":"1","key":"653_CR22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.puhe.2014.10.016","volume":"129","author":"ZG Zhao","year":"2015","unstructured":"Zhao ZG, Cheng JQ, Xu SL, Hou WL, Richardus JH. A quality assessment index framework for public health services: a Delphi study. Public Health. 2015;129(1):43\u201351.","journal-title":"Public Health"},{"issue":"4","key":"653_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-082930","volume":"14","author":"M Liu","year":"2024","unstructured":"Liu M, Yu Q, Liu Y. Developing quality indicators for cancer hospitals in China: a national modified delphi process. BMJ Open. 2024;14(4):e082930.","journal-title":"BMJ Open"},{"issue":"1","key":"653_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s41256-024-00367-w","volume":"9","author":"H Sun","year":"2024","unstructured":"Sun H, Wang Y, Cai H, Wang P, Jiang J, Shi C, et al. The development of a performance evaluation index system for Chinese Centers for Disease Control and Prevention: a Delphi consensus study. Glob Health Res Policy. 2024;9(1):28.","journal-title":"Glob Health Res Policy"},{"issue":"4","key":"653_CR25","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/FM9.0000000000000201","volume":"5","author":"T Li","year":"2023","unstructured":"Li T, Liu Z, Yang H, Hu Y. Using the Delphi technique to achieve consensus on prevention and treatment of preterm single birth in China. Maternal-Fetal Med. 2023;5(4):206\u201312.","journal-title":"Maternal-Fetal Med"},{"issue":"1","key":"653_CR26","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159\u201374.","journal-title":"Biometrics"},{"issue":"2","key":"653_CR27","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/00000658-196802000-00015","volume":"167","author":"FD Foley","year":"1968","unstructured":"Foley FD, Moncrief JA, Mason AD Jr. Pathology of the lung in fatally burned patients. Ann Surg. 1968;167(2):251\u201364.","journal-title":"Ann Surg"},{"issue":"6","key":"653_CR28","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.burns.2003.12.019","volume":"30","author":"AM Fecher","year":"2004","unstructured":"Fecher AM, O\u2019mara MS, Goldfarb IW, Slater H, Garvin R, Birdas TJ, et al. Analysis of deep vein thrombosis in burn patients. Burns. 2004;30(6):591\u20133.","journal-title":"Burns"},{"issue":"6","key":"653_CR29","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1097\/BCR.0b013e31822dc3c7","volume":"32","author":"J Bushwitz","year":"2011","unstructured":"Bushwitz J, Leclaire A, He J, Mozingo D. Clinically significant venous thromboembolic complications in burn patients receiving unfractionated heparin or enoxaparin as prophylaxis. J Burn Care Res. 2011;32(6):578\u201382.","journal-title":"J Burn Care Res"},{"issue":"2","key":"653_CR30","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/00004630-200103000-00008","volume":"22","author":"WL Wahl","year":"2001","unstructured":"Wahl WL, Brandt MM. Potential risk factors for deep venous thrombosis in burn patients. J Burn Care Rehabil. 2001;22(2):128\u201331.","journal-title":"J Burn Care Rehabil"},{"issue":"3","key":"653_CR31","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1097\/00005373-200103000-00014","volume":"50","author":"DT Harrington","year":"2001","unstructured":"Harrington DT, Mozingo DW, Cancio L, Bird P, Jordan B, Goodwin CW. Thermally injured patients are at significant risk for thromboembolic complications. J Trauma. 2001;50(3):495\u20139.","journal-title":"J Trauma"},{"issue":"3","key":"653_CR32","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/BCR.0b013e31827819a1","volume":"34","author":"F Mullins","year":"2013","unstructured":"Mullins F, Mian MA, Jenkins D, Brandigi C, Shaver JR, Friedman B, et al. Thromboembolic complications in burn patients and associated risk factors. J Burn Care Res. 2013;34(3):355\u201360.","journal-title":"J Burn Care Res"},{"issue":"8","key":"653_CR33","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/j.burns.2016.08.007","volume":"42","author":"RB Ahuja","year":"2016","unstructured":"Ahuja RB, Bansal P, Pradhan GS, Subberwal M. An analysis of deep vein thrombosis in burn patients (part II): a randomized and controlled study of thrombo-prophylaxis with low molecular weight heparin. Burns. 2016;42(8):1693\u20138.","journal-title":"Burns"},{"issue":"1","key":"653_CR34","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1097\/BCR.0000000000000093","volume":"36","author":"SS Satahoo","year":"2015","unstructured":"Satahoo SS, Parikh PP, Naranjo D, Davis JS, Duncan RC, Pizano LR, et al. Are burn patients really at risk for thrombotic events? J Burn Care Res. 2015;36(1):100\u20134.","journal-title":"J Burn Care Res"},{"issue":"8","key":"653_CR35","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1016\/j.bjps.2020.12.011","volume":"74","author":"P Lu","year":"2021","unstructured":"Lu P, Harms KA, Paul E, Bortz H, Lo C, Cleland H. Venous thromboembolism in burns patients: Are we underestimating the risk and underdosing our prophylaxis? J Plast Reconstr Aesthet Surg. 2021;74(8):1814\u201323.","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"1","key":"653_CR36","first-page":"54","volume":"36","author":"W Zhang","year":"2020","unstructured":"Zhang W, Zhang JF, Wang M, Xia CD, Wang LJ, Liu BH, et al. Occurrence of deep venous thrombosis in adult burn patients and its risk factors. Zhonghua Shao Shang Za Zhi. 2020;36(1):54\u20137.","journal-title":"Zhonghua Shao Shang Za Zhi"},{"issue":"4","key":"653_CR37","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1097\/00000658-199004000-00019","volume":"211","author":"M Wait","year":"1990","unstructured":"Wait M, Hunt JL, Purdue GF. Duplex scanning of central vascular access sites in burn patients. Ann Surg. 1990;211(4):499\u2013503.","journal-title":"Ann Surg"},{"issue":"2","key":"653_CR38","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/00004630-200203000-00005","volume":"23","author":"WL Wahl","year":"2002","unstructured":"Wahl WL, Brandt MM, Ahrns KS, Zajkowski PJ, Proctor MC, Wakefield TW, et al. Venous thrombosis incidence in burn patients: preliminary results of a prospective study. J Burn Care Rehabil. 2002;23(2):97\u2013102.","journal-title":"J Burn Care Rehabil"},{"issue":"6","key":"653_CR39","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1097\/01.TA.0000057149.42968.1D","volume":"55","author":"LA Wibbenmeyer","year":"2003","unstructured":"Wibbenmeyer LA, Hoballah JJ, Amelon MJ, Chang PX, Loret De Mola RM, Lewis RD 2nd, et al. The prevalence of venous thromboembolism of the lower extremity among thermally injured patients determined by duplex sonography. J Trauma. 2003;55(6):1162\u20137.","journal-title":"J Trauma"},{"issue":"1","key":"653_CR40","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/BCR.0b013e318204b2ff","volume":"32","author":"CJ Pannucci","year":"2011","unstructured":"Pannucci CJ, Osborne NH, Wahl WL. Venous thromboembolism in thermally injured patients: analysis of the National Burn Repository. J Burn Care Res. 2011;32(1):6\u201312.","journal-title":"J Burn Care Res"},{"issue":"1","key":"653_CR41","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1001\/archinte.164.1.17","volume":"164","author":"SR Kahn","year":"2004","unstructured":"Kahn SR, Ginsberg JS. Relationship between deep venous thrombosis and the postthrombotic syndrome. Arch Intern Med. 2004;164(1):17\u201326.","journal-title":"Arch Intern Med"},{"issue":"1","key":"653_CR42","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1378\/chest.110.1.303","volume":"110","author":"P Egermayer","year":"1996","unstructured":"Egermayer P. The mortality of untreated pulmonary embolism. Chest. 1996;110(1):303.","journal-title":"Chest"},{"issue":"2","key":"653_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13020362","volume":"13","author":"AB Dicks","year":"2024","unstructured":"Dicks AB, Moussallem E, Stanbro M, Walls J, Gandhi S, Gray BH. A comprehensive review of risk factors and thrombophilia evaluation in venous thromboembolism. J Clin Med. 2024;13(2):362.","journal-title":"J Clin Med"},{"issue":"7","key":"653_CR44","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1097\/00005373-197307000-00006","volume":"13","author":"GD Warden","year":"1973","unstructured":"Warden GD, Wilmore DW, Pruitt BA Jr. Central venous thrombosis: a hazard of medical progress. J Trauma. 1973;13(7):620\u20136.","journal-title":"J Trauma"},{"key":"653_CR45","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/bjs.18004821103","volume":"48","author":"S Sevitt","year":"1961","unstructured":"Sevitt S, Gallagher N. Venous thrombosis and pulmonary embolism. A clinico-pathological study in injured and burned patients. Br J Surg. 1961;48:475\u201389.","journal-title":"Br J Surg"},{"issue":"7","key":"653_CR46","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.burns.2011.06.006","volume":"37","author":"N Abedi","year":"2011","unstructured":"Abedi N, Papp A. A survey of current practice patterns in prophylaxis against venous thromboembolism (VTE) and gastrointestinal (GI) ulceration among Canadian burn centers. Burns. 2011;37(7):1182\u20136.","journal-title":"Burns"},{"issue":"8","key":"653_CR47","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.burns.2005.06.011","volume":"31","author":"RE Ferguson","year":"2005","unstructured":"Ferguson RE, Critchfield A, Leclaire A, Ajkay N, Vasconez HC. Current practice of thromboprophylaxis in the burn population: a survey study of 84 US burn centers. Burns. 2005;31(8):964\u20136.","journal-title":"Burns"},{"issue":"6","key":"653_CR48","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.burns.2019.04.003","volume":"45","author":"PV Vermaak","year":"2019","unstructured":"Vermaak PV, D\u2019Asta F, Provins J, Farr M, Wilson YT. Thromboprophylaxis in adult and paediatric burn patients: a survey of practice in the United Kingdom. Burns. 2019;45(6):1379\u201385.","journal-title":"Burns"},{"issue":"23 Suppl 1","key":"653_CR49","first-page":"I9","volume":"107","author":"FA Anderson Jr","year":"2003","unstructured":"Anderson FA Jr, Spencer FA. Risk factors for venous thromboembolism. Circulation. 2003;107(23 Suppl 1):I9\u2013I16.","journal-title":"Circulation"},{"issue":"4","key":"653_CR50","doi-asserted-by":"publisher","first-page":"e370","DOI":"10.1097\/CCM.0000000000005382","volume":"50","author":"A Tran","year":"2022","unstructured":"Tran A, Fernando SM, Rochwerg B, Cook DJ, Crowther MA, Fowler RA, et al. Prognostic factors associated with development of venous thromboembolism in critically ill patients-a systematic review and meta-analysis. Crit Care Med. 2022;50(4):e370\u201381.","journal-title":"Crit Care Med"},{"issue":"1","key":"653_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-022-03599-y","volume":"22","author":"L Li","year":"2022","unstructured":"Li L, Zhen J, Huang L, Zhou J, Yao L, Xu L, et al. The risk factors for deep venous thrombosis in critically ill older adult patients: a subgroup analysis of a prospective, multicenter, observational study. BMC Geriatr. 2022;22(1):977.","journal-title":"BMC Geriatr"},{"issue":"3","key":"653_CR52","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1177\/1076029615604048","volume":"22","author":"GV Fontaine","year":"2016","unstructured":"Fontaine GV, Vigil E, Wohlt PD, Lloyd JF, Evans RS, Collingridge DS, et al. Venous thromboembolism in critically ill medical patients receiving chemoprophylaxis: a focus on obesity and other risk factors. Clin Appl Thromb Hemost. 2016;22(3):265\u201373.","journal-title":"Clin Appl Thromb Hemost"},{"issue":"6 Suppl","key":"653_CR53","doi-asserted-by":"publisher","first-page":"381S","DOI":"10.1378\/chest.08-0656","volume":"133","author":"WH Geerts","year":"2008","unstructured":"Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, et al. Prevention of venous thromboembolism: American college of chest physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133(6 Suppl):381S-453S.","journal-title":"Chest"},{"issue":"1","key":"653_CR54","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/jbcr\/irz121","volume":"41","author":"H Peng","year":"2020","unstructured":"Peng H, Yue L, Gao H, Zheng R, Liang P, Wang A, et al. Risk assessment of deep venous thrombosis and its influencing factors in burn patients. J Burn Care Res. 2020;41(1):113\u201320.","journal-title":"J Burn Care Res"},{"issue":"4","key":"653_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043169","volume":"24","author":"D Pastori","year":"2023","unstructured":"Pastori D, Cormaci VM, Marucci S, Franchino G, Del Sole F, Capozza A, et al. A comprehensive review of risk factors for venous thromboembolism: from epidemiology to pathophysiology. Int J Mol Sci. 2023;24(4):3169.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"653_CR56","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/jbcr\/iraa143","volume":"42","author":"A Liu","year":"2021","unstructured":"Liu A, Minasian RA, Maniago E, Justin Gillenwater T, Garner WL, Yenikomshian HA. Venous thromboembolism chemoprophylaxis in burn patients: a literature review and single-institution experience. J Burn Care Res. 2021;42(1):18\u201322.","journal-title":"J Burn Care Res"},{"issue":"Suppl 3","key":"653_CR57","first-page":"304","volume":"17","author":"JA Caprini","year":"1991","unstructured":"Caprini JA, Arcelus JI, Hasty JH, Tamhane AC, Fabrega F. Clinical assessment of venous thromboembolic risk in surgical patients. Semin Thromb Hemost. 1991;17(Suppl 3):304\u201312.","journal-title":"Semin Thromb Hemost"},{"issue":"5","key":"653_CR58","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.amjmed.2015.10.027","volume":"129","author":"PJ Grant","year":"2016","unstructured":"Grant PJ, Greene MT, Chopra V, Bernstein SJ, Hofer TP, Flanders SA. Assessing the Caprini score for risk assessment of venous thromboembolism in hospitalized medical patients. Am J Med. 2016;129(5):528\u201335.","journal-title":"Am J Med"},{"issue":"6","key":"653_CR59","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.jvsv.2022.05.003","volume":"10","author":"H Hayssen","year":"2022","unstructured":"Hayssen H, Cires-Drouet R, Englum B, Nguyen P, Sahoo S, Mayorga-Carlin M, et al. Systematic review of venous thromboembolism risk categories derived from Caprini score. J Vasc Surg Venous Lymphat Disord. 2022;10(6):1401-9.e7.","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"issue":"11","key":"653_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpsurg.2022.101221","volume":"59","author":"S Wilson","year":"2022","unstructured":"Wilson S, Chen X, Cronin M, Dengler N, Enker P, Krauss ES, et al. Thrombosis prophylaxis in surgical patients using the Caprini risk score. Curr Probl Surg. 2022;59(11):101221.","journal-title":"Curr Probl Surg"},{"issue":"7","key":"653_CR61","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1177\/1076029615575344","volume":"22","author":"L Gharaibeh","year":"2016","unstructured":"Gharaibeh L, Albsoul-Younes A, Younes N. Evaluation of VTE prophylaxis in an educational hospital: comparison between the institutional guideline (Caprini 2006) and the ACCP guideline (ninth edition). Clin Appl Thromb Hemost. 2016;22(7):627\u201332.","journal-title":"Clin Appl Thromb Hemost"},{"issue":"1","key":"653_CR62","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.burns.2018.08.006","volume":"45","author":"Q Li","year":"2019","unstructured":"Li Q, Ba T, Wang LF, Chen Q, Li F, Xue Y. Stratification of venous thromboembolism risk in burn patients by Caprini score. Burns. 2019;45(1):140\u20135.","journal-title":"Burns"},{"issue":"4","key":"653_CR63","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1007\/s13346-017-0413-4","volume":"8","author":"MT Kalathottukaren","year":"2018","unstructured":"Kalathottukaren MT, Haynes CA, Kizhakkedathu JN. Approaches to prevent bleeding associated with anticoagulants: current status and recent developments. Drug Deliv Transl Res. 2018;8(4):928\u201344.","journal-title":"Drug Deliv Transl Res"},{"key":"653_CR64","doi-asserted-by":"publisher","first-page":"107602962311569","DOI":"10.1177\/10760296231156908","volume":"29","author":"J Qiao","year":"2023","unstructured":"Qiao J, Feng J, Hu W, Wu Y. Risk factor analysis of postoperative venous thromboembolism in patients after thoracoscopic lobectomy. Clin Appl Thromb Hemost. 2023;29:10760296231156908.","journal-title":"Clin Appl Thromb Hemost"},{"issue":"3","key":"653_CR65","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1097\/BCR.0b013e318217f966","volume":"32","author":"CJ Pannucci","year":"2011","unstructured":"Pannucci CJ, Diaz JA, Wahl WL. Temporal changes in deep venous thrombosis risk after electrical injury. J Burn Care Res. 2011;32(3):442\u20136.","journal-title":"J Burn Care Res"},{"issue":"1","key":"653_CR66","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1538-7836.2009.03678.x","volume":"8","author":"S Schulman","year":"2010","unstructured":"Schulman S, Angeras U, Bergqvist D, Eriksson B, Lassen MR, Fisher W. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients. J Thromb Haemost. 2010;8(1):202\u20134.","journal-title":"J Thromb Haemost"},{"issue":"8","key":"653_CR67","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1111\/jth.15776","volume":"20","author":"PL Den Exter","year":"2022","unstructured":"Den Exter PL, Woller SC, Robert-Ebadi H, Masias C, Morange PE, Castelli D, et al. Management of bleeding risk in patients who receive anticoagulant therapy for venous thromboembolism: communication from the ISTH SSC Subcommittee on predictive and diagnostic variables in thrombotic disease. J Thromb Haemost. 2022;20(8):1910\u20139.","journal-title":"J Thromb Haemost"},{"issue":"13","key":"653_CR68","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1001\/jama.2022.16815","volume":"328","author":"Y Freund","year":"2022","unstructured":"Freund Y, Cohen-Aubart F, Bloom B. Acute pulmonary embolism: a review. JAMA. 2022;328(13):1336\u201345.","journal-title":"JAMA"},{"issue":"5","key":"653_CR69","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1378\/chest.10-0134","volume":"138","author":"R Pisters","year":"2010","unstructured":"Pisters R, Lane DA, Nieuwlaat R, De Vos CB, Crijns HJ, Lip GY. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest. 2010;138(5):1093\u2013100.","journal-title":"Chest"},{"issue":"5","key":"653_CR70","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1001\/archinte.159.5.457","volume":"159","author":"PM Kuijer","year":"1999","unstructured":"Kuijer PM, Hutten BA, Prins MH, Buller HR. Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism. Arch Intern Med. 1999;159(5):457\u201360.","journal-title":"Arch Intern Med"},{"issue":"5","key":"653_CR71","volume":"133","author":"JLI Burggraaf","year":"2023","unstructured":"Burggraaf JLI, Van Rein N, Klok FA, Cannegieter SC. How to predict recurrent venous thromboembolism and bleeding? A review of recent advances and their implications. Pol Arch Intern Med. 2023;133(5):14692.","journal-title":"Pol Arch Intern Med"},{"key":"653_CR72","volume":"7","author":"LA Price","year":"2007","unstructured":"Price LA, Thombs B, Chen CL, Milner SM. Liver disease in burn injury: evidence from a national sample of 31,338 adult patients. J Burns Wounds. 2007;7:e1.","journal-title":"J Burns Wounds"},{"issue":"1","key":"653_CR73","first-page":"12","volume":"26","author":"SS Emara","year":"2013","unstructured":"Emara SS, Alzaylai AA. Renal failure in burn patients: a review. Ann Burns Fire Disasters. 2013;26(1):12\u20135.","journal-title":"Ann Burns Fire Disasters"},{"issue":"5","key":"653_CR74","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1093\/jn\/128.5.797","volume":"128","author":"DA De-Souza","year":"1998","unstructured":"De-Souza DA, Greene LJ. Pharmacological nutrition after burn injury. J Nutr. 1998;128(5):797\u2013803.","journal-title":"J Nutr"},{"issue":"5","key":"653_CR75","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1111\/jth.13283","volume":"14","author":"GJ Glas","year":"2016","unstructured":"Glas GJ, Levi M, Schultz MJ. Coagulopathy and its management in patients with severe burns. J Thromb Haemost. 2016;14(5):865\u201374.","journal-title":"J Thromb Haemost"},{"issue":"1","key":"653_CR76","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41572-020-0145-5","volume":"6","author":"MG Jeschke","year":"2020","unstructured":"Jeschke MG, Van Baar ME, Choudhry MA, Chung KK, Gibran NS, Logsetty S. Burn injury. Nat Rev Dis Primers. 2020;6(1):11.","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"653_CR77","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.burns.2023.12.014","volume":"50","author":"C Schaller","year":"2024","unstructured":"Schaller C, Petitpierre A, Von Felten S, Rittirsch D, Kim BS, Giovanoli P, et al. Thromboembolic events in burn patients: an analysis of risk factors and different anticoagulants. Burns. 2024;50(3):569\u201377.","journal-title":"Burns"},{"issue":"2","key":"653_CR78","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60020258","volume":"60","author":"EM Bordeanu-Diaconescu","year":"2024","unstructured":"Bordeanu-Diaconescu EM, Grosu-Bularda A, Frunza A, Grama S, Andrei MC, Neagu TP, et al. Venous thromboembolism in burn patients: a 5-year retrospective study. Medicina (Kaunas). 2024;60(2):258.","journal-title":"Medicina (Kaunas)"},{"issue":"8","key":"653_CR79","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1016\/j.burns.2016.08.005","volume":"42","author":"RB Ahuja","year":"2016","unstructured":"Ahuja RB, Bansal P, Pradhan GS, Subberwal M. An analysis of deep vein thrombosis in burn patients (Part 1): comparison of D-dimer and Doppler ultrasound as screening tools. Burns. 2016;42(8):1686\u201392.","journal-title":"Burns"},{"issue":"8","key":"653_CR80","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.crad.2015.04.007","volume":"70","author":"G Abdalla","year":"2015","unstructured":"Abdalla G, Fawzi Matuk R, Venugopal V, Verde F, Magnuson TH, Schweitzer MA, et al. The diagnostic accuracy of magnetic resonance venography in the detection of deep venous thrombosis: a systematic review and meta-analysis. Clin Radiol. 2015;70(8):858\u201371.","journal-title":"Clin Radiol"},{"issue":"2","key":"653_CR81","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/ajum.12188","volume":"23","author":"D Canty","year":"2020","unstructured":"Canty D, Mufti K, Bridgford L, Denault A. Point-of-care ultrasound for deep venous thrombosis of the lower limb. Australas J Ultrasound Med. 2020;23(2):111\u201320.","journal-title":"Australas J Ultrasound Med"},{"issue":"4","key":"653_CR82","first-page":"1035","volume":"109","author":"M Franchini","year":"2024","unstructured":"Franchini M, Focosi D, Pezzo MP, Mannucci PM. How we manage a high D-dimer. Haematologica. 2024;109(4):1035\u201345.","journal-title":"Haematologica"},{"issue":"4","key":"653_CR83","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1055\/s-0037-1599155","volume":"43","author":"M Wiegele","year":"2017","unstructured":"Wiegele M, Kozek-Langenecker S, Schaden E. Point-of-care testing in burn patients. Semin Thromb Hemost. 2017;43(4):433\u20138.","journal-title":"Semin Thromb Hemost"},{"issue":"10","key":"653_CR84","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.3324\/haematol.2011.060657","volume":"97","author":"RA Douma","year":"2012","unstructured":"Douma RA, Tan M, Schutgens RE, Bates SM, Perrier A, Legnani C, et al. Using an age-dependent D-dimer cut-off value increases the number of older patients in whom deep vein thrombosis can be safely excluded. Haematologica. 2012;97(10):1507\u201313.","journal-title":"Haematologica"},{"issue":"1","key":"653_CR85","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/TA.0b013e3182984911","volume":"75","author":"RM Van Haren","year":"2013","unstructured":"Van Haren RM, Thorson CM, Valle EJ, Busko AM, Guarch GA, Andrews DM, et al. Hypercoagulability after burn injury. J Trauma Acute Care Surg. 2013;75(1):37\u201343.","journal-title":"J Trauma Acute Care Surg"},{"issue":"6","key":"653_CR86","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1097\/BCR.0b013e3181f93597","volume":"31","author":"CJ Pannucci","year":"2010","unstructured":"Pannucci CJ, Osborne NH, Jaber RM, Cederna PS, Wahl WL. Early fasciotomy in electrically injured patients as a marker for injury severity and deep venous thrombosis risk: an analysis of the National Burn Repository. J Burn Care Res. 2010;31(6):882\u20137.","journal-title":"J Burn Care Res"},{"issue":"1","key":"653_CR87","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/BCR.0b013e318234d8b5","volume":"33","author":"CJ Pannucci","year":"2012","unstructured":"Pannucci CJ, Osborne NH, Wahl WL. Creation and validation of a simple venous thromboembolism risk scoring tool for thermally injured patients: analysis of the National Burn Repository. J Burn Care Res. 2012;33(1):20\u20135.","journal-title":"J Burn Care Res"},{"issue":"1","key":"653_CR88","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/BCR.0b013e318234d8c7","volume":"33","author":"CJ Pannucci","year":"2012","unstructured":"Pannucci CJ, Osborne NH, Park HS, Wahl WL. Acquired inpatient risk factors for venous thromboembolism after thermal injury. J Burn Care Res. 2012;33(1):84\u20138.","journal-title":"J Burn Care Res"},{"issue":"2","key":"653_CR89","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jvsv.2019.09.008","volume":"8","author":"CO Audu","year":"2020","unstructured":"Audu CO, Gordon AE, Obi AT, Wakefield TW, Henke PK. Inflammatory biomarkers in deep venous thrombosis organization, resolution, and post-thrombotic syndrome. J Vasc Surg Venous Lymphat Disord. 2020;8(2):299\u2013305.","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"issue":"12","key":"653_CR90","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1111\/jth.14314","volume":"16","author":"SG Fronas","year":"2018","unstructured":"Fronas SG, Wik HS, Dahm AEA, Jorgensen CT, Gleditsch J, Raouf N, et al. Safety of D-dimer testing as a stand-alone test for the exclusion of deep vein thrombosis as compared with other strategies. J Thromb Haemost. 2018;16(12):2471\u201381.","journal-title":"J Thromb Haemost"},{"issue":"11","key":"653_CR91","first-page":"716","volume":"100","author":"A Randel","year":"2019","unstructured":"Randel A. Diagnosing VTE: guidelines from the American Society of Hematology. Am Fam Physician. 2019;100(11):716\u20137.","journal-title":"Am Fam Physician"},{"issue":"2","key":"653_CR92","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","volume":"149","author":"C Kearon","year":"2016","unstructured":"Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016;149(2):315\u201352.","journal-title":"Chest"},{"issue":"2 Suppl","key":"653_CR93","doi-asserted-by":"publisher","first-page":"e278S","DOI":"10.1378\/chest.11-2404","volume":"141","author":"Y Falck-Ytter","year":"2012","unstructured":"Falck-Ytter Y, Francis CW, Johanson NA, Curley C, Dahl OE, Schulman S, et al. Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e278S\u2013e325S.","journal-title":"Chest"},{"issue":"6","key":"653_CR94","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1097\/00004630-200211000-00010","volume":"23","author":"WL Wahl","year":"2002","unstructured":"Wahl WL, Brandt MM, Ahrns K, Corpron CA, Franklin GA. The utility of D-dimer levels in screening for thromboembolic complications in burn patients. J Burn Care Rehabil. 2002;23(6):439\u201343.","journal-title":"J Burn Care Rehabil"},{"issue":"1","key":"653_CR95","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.burns.2018.09.020","volume":"45","author":"M Wiegele","year":"2019","unstructured":"Wiegele M, Schaden E, Koch S, Bauer D, Krall C, Adelmann D. Thrombin generation in patients with severe thermal injury. Burns. 2019;45(1):54\u201362.","journal-title":"Burns"},{"issue":"2","key":"653_CR96","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3947\/ic.2013.45.2.194","volume":"45","author":"HG Lee","year":"2013","unstructured":"Lee HG, Jang J, Choi JE, Chung DC, Han JW, Woo H, et al. Blood stream infections in patients in the burn intensive care unit. Infect Chemother. 2013;45(2):194\u2013201.","journal-title":"Infect Chemother"},{"issue":"4","key":"653_CR97","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.annemergmed.2008.05.023","volume":"52","author":"JA Kline","year":"2008","unstructured":"Kline JA, O\u2019malley PM, Tayal VS, Snead GR, Mitchell AM. Emergency clinician-performed compression ultrasonography for deep venous thrombosis of the lower extremity. Ann Emerg Med. 2008;52(4):437\u201345.","journal-title":"Ann Emerg Med"},{"issue":"6","key":"653_CR98","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0895-6111(97)00027-X","volume":"21","author":"N Glajchen","year":"1997","unstructured":"Glajchen N, Shapiro RS. Underassessment of lower extremity deep venous thrombosis using color flow Doppler compared to compression sonography. Comput Med Imaging Graph. 1997;21(6):331\u20135.","journal-title":"Comput Med Imaging Graph"},{"issue":"3","key":"653_CR99","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1148\/radiology.192.3.8058929","volume":"192","author":"BD Lewis","year":"1994","unstructured":"Lewis BD, James EM, Welch TJ, Joyce JW, Hallett JW, Weaver AL. Diagnosis of acute deep venous thrombosis of the lower extremities: prospective evaluation of color Doppler flow imaging versus venography. Radiology. 1994;192(3):651\u20135.","journal-title":"Radiology"},{"issue":"14","key":"653_CR100","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1001\/jama.300.14.1653","volume":"300","author":"E Bernardi","year":"2008","unstructured":"Bernardi E, Camporese G, Buller HR, Siragusa S, Imberti D, Berchio A, et al. Serial 2-point ultrasonography plus D-dimer vs whole-leg color-coded Doppler ultrasonography for diagnosing suspected symptomatic deep vein thrombosis: a randomized controlled trial. JAMA. 2008;300(14):1653\u20139.","journal-title":"JAMA"},{"issue":"8","key":"653_CR101","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1111\/j.1538-7836.2010.03938.x","volume":"8","author":"M Carrier","year":"2010","unstructured":"Carrier M, Righini M, Wells PS, Perrier A, Anderson DR, Rodger MA, et al. Subsegmental pulmonary embolism diagnosed by computed tomography: incidence and clinical implications. A systematic review and meta-analysis of the management outcome studies. J Thromb Haemost. 2010;8(8):1716\u201322.","journal-title":"J Thromb Haemost"},{"issue":"22","key":"653_CR102","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1056\/NEJMoa052367","volume":"354","author":"PD Stein","year":"2006","unstructured":"Stein PD, Fowler SE, Goodman LR, Gottschalk A, Hales CA, Hull RD, et al. Multidetector computed tomography for acute pulmonary embolism. N Engl J Med. 2006;354(22):2317\u201327.","journal-title":"N Engl J Med"},{"issue":"4","key":"653_CR103","doi-asserted-by":"publisher","first-page":"971","DOI":"10.2214\/ajr.167.4.8819396","volume":"167","author":"JP Laissy","year":"1996","unstructured":"Laissy JP, Cinqualbre A, Loshkajian A, Henry-Feugeas MC, Crestani B, Riquelme C, et al. Assessment of deep venous thrombosis in the lower limbs and pelvis: MR venography versus duplex Doppler sonography. AJR Am J Roentgenol. 1996;167(4):971\u20135.","journal-title":"AJR Am J Roentgenol"},{"issue":"14","key":"653_CR104","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1161\/CIRCULATIONAHA.117.030687","volume":"137","author":"L Needleman","year":"2018","unstructured":"Needleman L, Cronan JJ, Lilly MP, Merli GJ, Adhikari S, Hertzberg BS, et al. Ultrasound for lower extremity deep venous thrombosis: multidisciplinary recommendations from the Society of Radiologists in Ultrasound Consensus Conference. Circulation. 2018;137(14):1505\u201315.","journal-title":"Circulation"},{"issue":"6","key":"653_CR105","doi-asserted-by":"publisher","first-page":"493","DOI":"10.21037\/cdt.2016.12.06","volume":"6","author":"GY Karande","year":"2016","unstructured":"Karande GY, Hedgire SS, Sanchez Y, Baliyan V, Mishra V, Ganguli S, et al. Advanced imaging in acute and chronic deep vein thrombosis. Cardiovasc Diagn Ther. 2016;6(6):493\u2013507.","journal-title":"Cardiovasc Diagn Ther"},{"issue":"8906","key":"653_CR106","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/S0140-6736(94)90240-2","volume":"343","author":"LM Jongbloets","year":"1994","unstructured":"Jongbloets LM, Lensing AW, Koopman MM, Buller HR, Ten Cate JW. Limitations of compression ultrasound for the detection of symptomless postoperative deep vein thrombosis. Lancet. 1994;343(8906):1142\u20134.","journal-title":"Lancet"},{"issue":"49","key":"653_CR107","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000040821","volume":"103","author":"D Yao","year":"2024","unstructured":"Yao D, Cao W, Liu X. Clinical manifestations and misdiagnosis factors of pulmonary embolism patients seeking treatment in cardiology. Medicine (Baltimore). 2024;103(49):e40821.","journal-title":"Medicine (Baltimore)"},{"issue":"13","key":"653_CR108","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13133722","volume":"13","author":"SE Thomas","year":"2024","unstructured":"Thomas SE, Weinberg I, Schainfeld RM, Rosenfield K, Parmar GM. Diagnosis of pulmonary embolism: a review of evidence-based approaches. J Clin Med. 2024;13(13):3722.","journal-title":"J Clin Med"},{"issue":"3","key":"653_CR109","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/jth.13234","volume":"14","author":"SM Bates","year":"2016","unstructured":"Bates SM, Takach Lapner S, Douketis JD, Kearon C, Julian J, Parpia S, et al. Rapid quantitative D-dimer to exclude pulmonary embolism: a prospective cohort management study. J Thromb Haemost. 2016;14(3):504\u20139.","journal-title":"J Thromb Haemost"},{"issue":"2","key":"653_CR110","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/SHK.0000000000001484","volume":"54","author":"RL Ball","year":"2020","unstructured":"Ball RL, Keyloun JW, Brummel-Ziedins K, Orfeo T, Palmieri TL, Johnson LS, et al. Burn-induced coagulopathies: a comprehensive review. Shock. 2020;54(2):154\u201367.","journal-title":"Shock"},{"issue":"1","key":"653_CR111","first-page":"26","volume":"25","author":"GS Abu-Sittah","year":"2012","unstructured":"Abu-Sittah GS, Sarhane KA, Dibo SA, Ibrahim A. Cardiovascular dysfunction in burns: review of the literature. Ann Burns Fire Disasters. 2012;25(1):26\u201337.","journal-title":"Ann Burns Fire Disasters"},{"issue":"9","key":"653_CR112","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11092533","volume":"11","author":"A Leidi","year":"2022","unstructured":"Leidi A, Bex S, Righini M, Berner A, Grosgurin O, Marti C. Risk stratification in patients with acute pulmonary embolism: current evidence and perspectives. J Clin Med. 2022;11(9):2533.","journal-title":"J Clin Med"},{"issue":"4","key":"653_CR113","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s10140-024-02249-7","volume":"31","author":"S Yaghoobpoor","year":"2024","unstructured":"Yaghoobpoor S, Fathi M, Taher HJ, Farhood AJ, Bahrami A, Eshraghi R, et al. Computed tomography pulmonary angiography (CTPA) for the detection of pulmonary embolism (PE) among trauma patients: a systematic review and meta-analysis. Emerg Radiol. 2024;31(4):567\u201380.","journal-title":"Emerg Radiol"},{"issue":"4","key":"653_CR114","doi-asserted-by":"publisher","first-page":"94","DOI":"10.5492\/wjccm.v1.i4.94","volume":"1","author":"YK Coban","year":"2012","unstructured":"Coban YK. Infection control in severely burned patients. World J Crit Care Med. 2012;1(4):94\u2013101.","journal-title":"World J Crit Care Med"},{"issue":"8","key":"653_CR115","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/j.burns.2021.09.015","volume":"47","author":"L Bright","year":"2021","unstructured":"Bright L, Van Der Lee L, Hince D, Wood FM, Edgar DW. Quantification of the negative impact of sedation and inotropic support on achieving early mobility in burn patients in ICU: a single center observational study. Burns. 2021;47(8):1756\u201365.","journal-title":"Burns"},{"issue":"4","key":"653_CR116","doi-asserted-by":"publisher","first-page":"E832","DOI":"10.9778\/cmajo.20200003","volume":"8","author":"BD Lau","year":"2020","unstructured":"Lau BD, Murphy P, Nastasi AJ, Seal S, Kraus PS, Hobson DB, et al. Effectiveness of ambulation to prevent venous thromboembolism in patients admitted to hospital: a systematic review. CMAJ Open. 2020;8(4):E832\u201343.","journal-title":"CMAJ Open"},{"issue":"2","key":"653_CR117","doi-asserted-by":"publisher","first-page":"186","DOI":"10.2522\/ptj.20110417","volume":"93","author":"DE Clark","year":"2013","unstructured":"Clark DE, Lowman JD, Griffin RL, Matthews HM, Reiff DA. Effectiveness of an early mobilization protocol in a trauma and burns intensive care unit: a retrospective cohort study. Phys Ther. 2013;93(2):186\u201396.","journal-title":"Phys Ther"},{"key":"653_CR118","doi-asserted-by":"publisher","DOI":"10.1093\/burnst\/tkaa044","volume":"9","author":"LM Tracy","year":"2021","unstructured":"Tracy LM, Cameron PA, Singer Y, Earnest A, Wood F, Cleland H, et al. Venous thromboembolism prophylaxis practice and its association with outcomes in Australia and New Zealand burns patients. Burns Trauma. 2021;9:tkaa044.","journal-title":"Burns Trauma"},{"issue":"11","key":"653_CR119","volume":"11","author":"A Sachdeva","year":"2018","unstructured":"Sachdeva A, Dalton M, Lees T. Graduated compression stockings for prevention of deep vein thrombosis. Cochrane Database Syst Rev. 2018;11(11):CD001484.","journal-title":"Cochrane Database Syst Rev"},{"key":"653_CR120","doi-asserted-by":"publisher","first-page":"1408334","DOI":"10.3389\/fcvm.2024.1408334","volume":"11","author":"Y Tong","year":"2024","unstructured":"Tong Y, Ying R, Niu M, Xu L. Effect of venous foot pump intervention on prevention of venous thromboembolism in patients with major orthopedic surgery: a systematic review and meta-analysis. Front Cardiovasc Med. 2024;11:1408334.","journal-title":"Front Cardiovasc Med"},{"issue":"23","key":"653_CR121","doi-asserted-by":"publisher","first-page":"3898","DOI":"10.1182\/bloodadvances.2019000975","volume":"3","author":"DR Anderson","year":"2019","unstructured":"Anderson DR, Morgano GP, Bennett C, Dentali F, Francis CW, Garcia DA, et al. American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients. Blood Adv. 2019;3(23):3898\u2013944.","journal-title":"Blood Adv"},{"issue":"5","key":"653_CR122","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1097\/TA.0000000000002830","volume":"89","author":"EJ Ley","year":"2020","unstructured":"Ley EJ, Brown CVR, Moore EE, Sava JA, Peck K, Ciesla DJ, et al. Updated guidelines to reduce venous thromboembolism in trauma patients: a Western Trauma Association critical decisions algorithm. J Trauma Acute Care Surg. 2020;89(5):971\u201381.","journal-title":"J Trauma Acute Care Surg"},{"issue":"2 Suppl","key":"653_CR123","doi-asserted-by":"publisher","first-page":"e227S","DOI":"10.1378\/chest.11-2297","volume":"141","author":"MK Gould","year":"2012","unstructured":"Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA, et al. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e227S \u2013 e277.","journal-title":"Chest"},{"issue":"2","key":"653_CR124","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.arth.2015.09.043","volume":"31","author":"JM Pavon","year":"2016","unstructured":"Pavon JM, Adam SS, Razouki ZA, Mcduffie JR, Lachiewicz PF, Kosinski AS, et al. Effectiveness of intermittent pneumatic compression devices for venous thromboembolism prophylaxis in high-risk surgical patients: a systematic review. J Arthroplasty. 2016;31(2):524\u201332.","journal-title":"J Arthroplasty"},{"issue":"2 Suppl","key":"653_CR125","doi-asserted-by":"publisher","first-page":"7S","DOI":"10.1378\/chest.1412S3","volume":"141","author":"GH Guyatt","year":"2012","unstructured":"Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schuunemann HJ, American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel. Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):7S-47S.","journal-title":"Chest"},{"issue":"7","key":"653_CR126","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0307602","volume":"19","author":"NY Kim","year":"2024","unstructured":"Kim NY, Ryu S, Kim YH. Effects of intermittent pneumatic compression devices interventions to prevent deep vein thrombosis in surgical patients: a systematic review and meta-analysis of randomized controlled trials. PLoS ONE. 2024;19(7):e0307602.","journal-title":"PLoS ONE"},{"key":"653_CR127","doi-asserted-by":"publisher","DOI":"10.1177\/1076029620913942","volume":"26","author":"Y Wang","year":"2020","unstructured":"Wang Y, Huang D, Wang M, Liang Z. Can intermittent pneumatic compression reduce the incidence of venous thrombosis in critically ill patients: a systematic review and meta-analysis. Clin Appl Thromb Hemost. 2020;26:1076029620913942.","journal-title":"Clin Appl Thromb Hemost"},{"issue":"1","key":"653_CR128","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/SLA.0000000000004556","volume":"274","author":"K Lobastov","year":"2021","unstructured":"Lobastov K, Sautina E, Alencheva E, Bargandzhiya A, Schastlivtsev I, Barinov V, et al. Intermittent pneumatic compression in addition to standard prophylaxis of postoperative venous thromboembolism in extremely high-risk patients (IPC SUPER): a randomized controlled trial. Ann Surg. 2021;274(1):63\u20139.","journal-title":"Ann Surg"},{"issue":"76","key":"653_CR129","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta19760","volume":"19","author":"M Dennis","year":"2015","unstructured":"Dennis M, Sandercock P, Graham C, Forbes J, Collaboration CT, Smith J. The Clots in Legs Or sTockings after Stroke (CLOTS) 3 trial: a randomised controlled trial to determine whether or not intermittent pneumatic compression reduces the risk of post-stroke deep vein thrombosis and to estimate its cost-effectiveness. Health Technol Assess. 2015;19(76):1\u201390.","journal-title":"Health Technol Assess"},{"issue":"2","key":"653_CR130","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3171\/2017.9.JNS17533","volume":"130","author":"J Prell","year":"2019","unstructured":"Prell J, Schenk G, Taute BM, Scheller C, Marquart C, Strauss C, et al. Reduced risk of venous thromboembolism with the use of intermittent pneumatic compression after craniotomy: a randomized controlled prospective study. J Neurosurg. 2019;130(2):622\u20138.","journal-title":"J Neurosurg"},{"issue":"1","key":"653_CR131","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-023-01135-8","volume":"13","author":"M Amer","year":"2023","unstructured":"Amer M, Alshahrani MS, Arabi YM, Al-Jedai A, Alshaqaq HM, Al-Sharydah A, et al. Saudi Critical Care Society clinical practice guidelines on the prevention of venous thromboembolism in adults with trauma: reviewed for evidence-based integrity and endorsed by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine. Ann Intensive Care. 2023;13(1):41.","journal-title":"Ann Intensive Care"},{"issue":"2 Suppl","key":"653_CR132","doi-asserted-by":"publisher","first-page":"e195S","DOI":"10.1378\/chest.11-2296","volume":"141","author":"SR Kahn","year":"2012","unstructured":"Kahn SR, Lim W, Dunn AS, Cushman M, Dentali F, Akl EA, et al. Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e195S\u2013e226S.","journal-title":"Chest"},{"key":"653_CR133","doi-asserted-by":"crossref","unstructured":"Pavon JM, Williams JW Jr, Adam SS, Razouki ZA, Mcduffie JR, Lachiewicz PF, et al. Effectiveness of intermittent pneumatic compression devices for venous thromboembolism prophylaxis in high-risk surgical and medical patients. Washington (DC); 2015.","DOI":"10.1016\/j.arth.2015.09.043"},{"issue":"3","key":"653_CR134","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/S0002-9610(97)89632-8","volume":"171","author":"E Flam","year":"1996","unstructured":"Flam E, Berry S, Coyle A, Dardik H, Raab L. Blood-flow augmentation of intermittent pneumatic compression systems used for prevention of deep vein thrombosis prior to surgery. Am J Surg. 1996;171(3):312\u20135.","journal-title":"Am J Surg"},{"issue":"2","key":"653_CR135","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1148\/radiol.2272011139","volume":"227","author":"S Patel","year":"2003","unstructured":"Patel S, Kazerooni EA, Cascade PN. Pulmonary embolism: optimization of small pulmonary artery visualization at multi-detector row CT. Radiology. 2003;227(2):455\u201360.","journal-title":"Radiology"},{"issue":"16","key":"653_CR136","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1001\/jama.2015.3780","volume":"313","author":"P Mismetti","year":"2015","unstructured":"Mismetti P, Laporte S, Pellerin O, Ennezat PV, Couturaud F, Elias A, et al. Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial. JAMA. 2015;313(16):1627\u201335.","journal-title":"JAMA"},{"issue":"1","key":"653_CR137","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1538-7836.2008.03217.x","volume":"7","author":"P Singh","year":"2009","unstructured":"Singh P, Lai HM, Lerner RG, Chugh T, Aronow WS. Guidelines and the use of inferior vena cava filters: a review of an institutional experience. J Thromb Haemost. 2009;7(1):65\u201371.","journal-title":"J Thromb Haemost"},{"issue":"3","key":"653_CR138","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1177\/000313480006600310","volume":"66","author":"J Still","year":"2000","unstructured":"Still J, Friedman B, Furman S, Cohen H, Gates C, Dawson J, et al. Experience with the insertion of vena caval filters in acutely burned patients. Am Surg. 2000;66(3):277\u20139.","journal-title":"Am Surg"},{"key":"653_CR139","doi-asserted-by":"publisher","first-page":"973","DOI":"10.2147\/DDDT.S38042","volume":"7","author":"M Di Nisio","year":"2013","unstructured":"Di Nisio M, Porreca E. Prevention of venous thromboembolism in hospitalized acutely ill medical patients: focus on the clinical utility of (low-dose) fondaparinux. Drug Des Devel Ther. 2013;7:973\u201380.","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"653_CR140","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/TA.0000000000001494","volume":"83","author":"BN Jacobs","year":"2017","unstructured":"Jacobs BN, Cain-Nielsen AH, Jakubus JL, Mikhail JN, Fath JJ, Regenbogen SE, et al. Unfractionated heparin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in trauma. J Trauma Acute Care Surg. 2017;83(1):151\u20138.","journal-title":"J Trauma Acute Care Surg"},{"key":"653_CR141","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111561","volume":"139","author":"M Qiu","year":"2021","unstructured":"Qiu M, Huang S, Luo C, Wu Z, Liang B, Huang H, et al. Pharmacological and clinical application of heparin progress: an essential drug for modern medicine. Biomed Pharmacother. 2021;139:111561.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"653_CR142","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/SAP.0b013e31821bd4bc","volume":"67","author":"MN Busche","year":"2011","unstructured":"Busche MN, Herold C, Kramer R, Knobloch K, Vogt PM, Rennekampff HO. Evaluation of prophylactic anticoagulation, deep venous thrombosis, and heparin-induced thrombocytopenia in 21 burn centers in Germany, Austria, and Switzerland. Ann Plast Surg. 2011;67(1):17\u201324.","journal-title":"Ann Plast Surg"},{"issue":"6","key":"653_CR143","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1097\/TA.0000000000001193","volume":"81","author":"GA Singer","year":"2016","unstructured":"Singer GA, Riggi G, Karcutskie CA, Vaghaiwalla TM, Lieberman HM, Ginzburg E, et al. Anti-Xa-guided enoxaparin thromboprophylaxis reduces rate of deep venous thromboembolism in high-risk trauma patients. J Trauma Acute Care Surg. 2016;81(6):1101\u20138.","journal-title":"J Trauma Acute Care Surg"},{"issue":"6","key":"653_CR144","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/BCR.0b013e3182a2a855","volume":"34","author":"I Faraklas","year":"2013","unstructured":"Faraklas I, Ghanem M, Brown A, Cochran A. Evaluation of an enoxaparin dosing calculator using burn size and weight. J Burn Care Res. 2013;34(6):621\u20137.","journal-title":"J Burn Care Res"},{"key":"653_CR145","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4363","volume":"366","author":"F Khan","year":"2019","unstructured":"Khan F, Rahman A, Carrier M, Kearon C, Weitz JI, Schulman S, et al. Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis. BMJ. 2019;366:l4363.","journal-title":"BMJ"},{"issue":"5","key":"653_CR146","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1182\/blood.2019002364","volume":"135","author":"C Kearon","year":"2020","unstructured":"Kearon C, Kahn SR. Long-term treatment of venous thromboembolism. Blood. 2020;135(5):317\u201325.","journal-title":"Blood"},{"issue":"6","key":"653_CR147","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/phar.2089","volume":"38","author":"A Shendre","year":"2018","unstructured":"Shendre A, Parmar GM, Dillon C, Beasley TM, Limdi NA. Influence of age on warfarin dose, anticoagulation control, and risk of hemorrhage. Pharmacotherapy. 2018;38(6):588\u201396.","journal-title":"Pharmacotherapy"},{"issue":"2","key":"653_CR148","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/jth.13912","volume":"16","author":"J Douxfils","year":"2018","unstructured":"Douxfils J, Ageno W, Samama CM, Lessire S, Ten Cate H, Verhamme P, et al. Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians. J Thromb Haemost. 2018;16(2):209\u201319.","journal-title":"J Thromb Haemost"},{"issue":"5","key":"653_CR149","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11051338","volume":"11","author":"B Lardinois","year":"2022","unstructured":"Lardinois B, Hardy M, Michaux I, Horlait G, Rotens T, Jacqmin H, et al. Monitoring of unfractionated heparin therapy in the intensive care unit using a point-of-care aPTT: a comparative, longitudinal observational study with laboratory-based aPTT and anti-xa activity measurement. J Clin Med. 2022;11(5):1338.","journal-title":"J Clin Med"},{"issue":"2","key":"653_CR150","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1097\/TA.0000000000003580","volume":"93","author":"K Verhoeff","year":"2022","unstructured":"Verhoeff K, Raffael K, Connell M, Kung JY, Strickland M, Parker A, et al. Relationship between anti-Xa level achieved with prophylactic low-molecular weight heparin and venous thromboembolism in trauma patients: a systematic review and meta-analysis. J Trauma Acute Care Surg. 2022;93(2):e61\u201370.","journal-title":"J Trauma Acute Care Surg"},{"key":"653_CR151","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.thromres.2021.04.019","volume":"203","author":"AM Marshall","year":"2021","unstructured":"Marshall AM, Trussell TM, Yee AM, Malone MP. Anti-Xa levels in critically ill children receiving enoxaparin for venothromboembolism prophylaxis. Thromb Res. 2021;203:117\u201320.","journal-title":"Thromb Res"},{"issue":"6","key":"653_CR152","first-page":"1557","volume":"71","author":"H Lin","year":"2011","unstructured":"Lin H, Faraklas I, Saffle J, Cochran A. Enoxaparin dose adjustment is associated with low incidence of venous thromboembolic events in acute burn patients. J Trauma. 2011;71(6):1557\u201361.","journal-title":"J Trauma"},{"issue":"1","key":"653_CR153","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/BCR.0b013e318204b346","volume":"32","author":"H Lin","year":"2011","unstructured":"Lin H, Faraklas I, Cochran A, Saffle J. Enoxaparin and antifactor Xa levels in acute burn patients. J Burn Care Res. 2011;32(1):1\u20135.","journal-title":"J Burn Care Res"},{"issue":"11","key":"653_CR154","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1001\/jamasurg.2016.1662","volume":"151","author":"A Ko","year":"2016","unstructured":"Ko A, Harada MY, Barmparas G, Chung K, Mason R, Yim DA, et al. Association between enoxaparin dosage adjusted by anti-factor Xa trough level and clinically evident venous thromboembolism after trauma. JAMA Surg. 2016;151(11):1006\u201313.","journal-title":"JAMA Surg"},{"key":"653_CR155","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ijsu.2018.01.023","volume":"51","author":"NK Dhillon","year":"2018","unstructured":"Dhillon NK, Smith EJT, Gillette E, Mason R, Barmparas G, Gewertz BL, et al. Trauma patients with lower extremity and pelvic fractures: should anti-factor Xa trough level guide prophylactic enoxaparin dose? Int J Surg. 2018;51:128\u201332.","journal-title":"Int J Surg"},{"issue":"4","key":"653_CR156","first-page":"874","volume":"68","author":"D Malinoski","year":"2010","unstructured":"Malinoski D, Jafari F, Ewing T, Ardary C, Conniff H, Baje M, et al. Standard prophylactic enoxaparin dosing leads to inadequate anti-Xa levels and increased deep venous thrombosis rates in critically ill trauma and surgical patients. J Trauma. 2010;68(4):874\u201380.","journal-title":"J Trauma"},{"issue":"2","key":"653_CR157","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1097\/TA.0000000000000087","volume":"76","author":"ME Droege","year":"2014","unstructured":"Droege ME, Mueller EW, Besl KM, Lemmink JA, Kramer EA, Athota KP, et al. Effect of a dalteparin prophylaxis protocol using anti-factor Xa concentrations on venous thromboembolism in high-risk trauma patients. J Trauma Acute Care Surg. 2014;76(2):450\u20136.","journal-title":"J Trauma Acute Care Surg"},{"issue":"1","key":"653_CR158","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/TA.0000000000003418","volume":"92","author":"RS Gates","year":"2022","unstructured":"Gates RS, Lollar DI, Collier BR, Smith J, Faulks ER, Gillen JR. Enoxaparin titrated by anti-Xa levels reduces venous thromboembolism in trauma patients. J Trauma Acute Care Surg. 2022;92(1):93\u20137.","journal-title":"J Trauma Acute Care Surg"},{"key":"653_CR159","doi-asserted-by":"publisher","DOI":"10.1093\/burnst\/tkab032","volume":"9","author":"LD Cato","year":"2021","unstructured":"Cato LD, Bailiff B, Price J, Ermogeneous C, Hazeldine J, Lester W, et al. Heparin resistance in severe thermal injury: a prospective cohort study. Burns Trauma. 2021;9:tkab032.","journal-title":"Burns Trauma"},{"issue":"12","key":"653_CR160","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.1016\/j.injury.2022.09.061","volume":"53","author":"Q Li","year":"2022","unstructured":"Li Q, Zhang T, Wang L, Li F, Chen Q, Cao S, et al. Clinical significance of R-TEG in severe burn patients with coagulation dysfunction. Injury. 2022;53(12):3993\u20139.","journal-title":"Injury"},{"issue":"4","key":"653_CR161","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.burns.2018.08.024","volume":"45","author":"H Welling","year":"2019","unstructured":"Welling H, Ostrowski SR, Stensballe J, Vestergaard MR, Partoft S, White J, et al. Management of bleeding in major burn surgery. Burns. 2019;45(4):755\u201362.","journal-title":"Burns"},{"issue":"11","key":"653_CR162","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1111\/jth.13486","volume":"14","author":"S Testa","year":"2016","unstructured":"Testa S, Legnani C, Tripodi A, Paoletti O, Pengo V, Abbate R, et al. Poor comparability of coagulation screening test with specific measurement in patients receiving direct oral anticoagulants: results from a multicenter\/multiplatform study. J Thromb Haemost. 2016;14(11):2194\u2013201.","journal-title":"J Thromb Haemost"},{"issue":"5","key":"653_CR163","doi-asserted-by":"publisher","first-page":"665","DOI":"10.5858\/arpa.2014-0170-OA","volume":"139","author":"JD Dias","year":"2015","unstructured":"Dias JD, Norem K, Doorneweerd DD, Thurer RL, Popovsky MA, Omert LA. Use of thromboelastography (TEG) for detection of new oral anticoagulants. Arch Pathol Lab Med. 2015;139(5):665\u201373.","journal-title":"Arch Pathol Lab Med"},{"issue":"8","key":"653_CR164","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1080\/17425255.2016.1194395","volume":"12","author":"E Sokolowska","year":"2016","unstructured":"Sokolowska E, Kalaska B, Miklosz J, Mogielnicki A. The toxicology of heparin reversal with protamine: past, present and future. Expert Opin Drug Metab Toxicol. 2016;12(8):897\u2013909.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"2","key":"653_CR165","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s11606-015-3466-4","volume":"31","author":"D Park","year":"2016","unstructured":"Park D, Southern W, Calvo M, Kushnir M, Solorzano C, Sinnet M, et al. Treatment with dalteparin is associated with a lower risk of bleeding compared to treatment with unfractionated heparin in patients with renal insufficiency. J Gen Intern Med. 2016;31(2):182\u20137.","journal-title":"J Gen Intern Med"},{"issue":"6","key":"653_CR166","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198285","volume":"13","author":"M Pai","year":"2018","unstructured":"Pai M, Adhikari NKJ, Ostermann M, Heels-Ansdell D, Douketis JD, Skrobik Y, et al. Low-molecular-weight heparin venous thromboprophylaxis in critically ill patients with renal dysfunction: a subgroup analysis of the PROTECT trial. PLoS ONE. 2018;13(6):e0198285.","journal-title":"PLoS ONE"},{"issue":"2","key":"653_CR167","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1177\/1358863X19898253","volume":"25","author":"M Hogan","year":"2020","unstructured":"Hogan M, Berger JS. Heparin-induced thrombocytopenia (HIT): review of incidence, diagnosis, and management. Vasc Med. 2020;25(2):160\u201373.","journal-title":"Vasc Med"},{"issue":"19","key":"653_CR168","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1093\/eurheartj\/ehy066","volume":"39","author":"B Rocca","year":"2018","unstructured":"Rocca B, Fox KAA, Ajjan RA, Andreotti F, Baigent C, Collet JP, et al. Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis. Eur Heart J. 2018;39(19):1672\u201386.","journal-title":"Eur Heart J"},{"issue":"6","key":"653_CR169","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1097\/BCR.0b013e3182a2a9f8","volume":"34","author":"A Brown","year":"2013","unstructured":"Brown A, Faraklas I, Ghanem M, Cochran A. Enoxaparin and antifactor Xa levels in pediatric acute burn patients. J Burn Care Res. 2013;34(6):628\u201332.","journal-title":"J Burn Care Res"},{"issue":"8","key":"653_CR170","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9080864","volume":"9","author":"P Cauchie","year":"2021","unstructured":"Cauchie P, Piagnerelli M. What do we know about thromboprophylaxis and its monitoring in critically ill patients? Biomedicines. 2021;9(8):864.","journal-title":"Biomedicines"},{"key":"653_CR171","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.thromres.2019.08.014","volume":"182","author":"SM Wasan","year":"2019","unstructured":"Wasan SM, Feland N, Grant R, Aston CE. Validation of apixaban anti-factor Xa assay and impact of body weight. Thromb Res. 2019;182:51\u20135.","journal-title":"Thromb Res"},{"key":"653_CR172","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jss.2021.02.034","volume":"265","author":"R Bigos","year":"2021","unstructured":"Bigos R, Solomon E, Dorfman JD, Ha M. A weight- and anti-Xa-guided enoxaparin dosing protocol for venous thromboembolism prophylaxis in intensive care unit trauma patients. J Surg Res. 2021;265:122\u201330.","journal-title":"J Surg Res"},{"issue":"5","key":"653_CR173","doi-asserted-by":"publisher","first-page":"425","DOI":"10.23736\/S0375-9393.22.16920-8","volume":"89","author":"N Zohar","year":"2023","unstructured":"Zohar N, Ellis MH, Dichtwald S, Meyer A, Zohar E, Ifrach N. Low molecular weight heparin for venous thromboembolism prophylaxis in general intensive care unit patients: an anti-factor Xa level-based approach. Minerva Anestesiol. 2023;89(5):425\u201333.","journal-title":"Minerva Anestesiol"},{"issue":"2","key":"653_CR174","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1016\/j.burns.2014.06.018","volume":"41","author":"R Sebastian","year":"2015","unstructured":"Sebastian R, Ghanem O, Diroma F, Milner SM, Price LA. Pulmonary embolism in burns, is there an evidence based prophylactic recommendation? Case report and review of literature. Burns. 2015;41(2):e4\u20137.","journal-title":"Burns"},{"issue":"2","key":"653_CR175","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1001\/jama.2012.164493","volume":"309","author":"G Piazza","year":"2013","unstructured":"Piazza G. Submassive pulmonary embolism. JAMA. 2013;309(2):171\u201380.","journal-title":"JAMA"},{"issue":"8","key":"653_CR176","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1164\/rccm.200506-862OC","volume":"172","author":"D Aujesky","year":"2005","unstructured":"Aujesky D, Obrosky DS, Stone RA, Auble TE, Perrier A, Cornuz J, et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med. 2005;172(8):1041\u20136.","journal-title":"Am J Respir Crit Care Med"},{"issue":"9785","key":"653_CR177","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0140-6736(11)60824-6","volume":"378","author":"D Aujesky","year":"2011","unstructured":"Aujesky D, Roy PM, Verschuren F, Righini M, Osterwalder J, Egloff M, et al. Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. Lancet. 2011;378(9785):41\u20138.","journal-title":"Lancet"},{"issue":"3","key":"653_CR178","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1183\/09031936.00030412","volume":"41","author":"W Zondag","year":"2013","unstructured":"Zondag W, Hiddinga BI, Crobach MJ, Labots G, Dolsma A, Durian M, et al. Hestia criteria can discriminate high- from low-risk patients with pulmonary embolism. Eur Respir J. 2013;41(3):588\u201392.","journal-title":"Eur Respir J"},{"issue":"15","key":"653_CR179","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1001\/archinternmed.2010.199","volume":"170","author":"D Jimenez","year":"2010","unstructured":"Jimenez D, Aujesky D, Moores L, Gomez V, Lobo JL, Uresandi F, et al. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med. 2010;170(15):1383\u20139.","journal-title":"Arch Intern Med"},{"issue":"12","key":"653_CR180","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.amjmed.2011.06.009","volume":"124","author":"G Piazza","year":"2011","unstructured":"Piazza G, Nguyen TN, Cios D, Labreche M, Hohlfelder B, Fanikos J, et al. Anticoagulation-associated adverse drug events. Am J Med. 2011;124(12):1136\u201342.","journal-title":"Am J Med"},{"issue":"16","key":"653_CR181","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1093\/eurheartj\/ehy136","volume":"39","author":"J Steffel","year":"2018","unstructured":"Steffel J, Verhamme P, Potpara TS, Albaladejo P, Antz M, Desteghe L, et al. The 2018 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J. 2018;39(16):1330\u201393.","journal-title":"Eur Heart J"},{"issue":"5","key":"653_CR182","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/jth.13670","volume":"15","author":"J Shaw","year":"2017","unstructured":"Shaw J, De Wit C, Le Gal G, Carrier M. Thrombotic and bleeding outcomes following perioperative interruption of direct oral anticoagulants in patients with venous thromboembolic disease. J Thromb Haemost. 2017;15(5):925\u201330.","journal-title":"J Thromb Haemost"},{"issue":"13\u201314","key":"653_CR183","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s00508-013-0390-7","volume":"125","author":"H Watzke","year":"2013","unstructured":"Watzke H, Metzler H, Weltermann A, Marschang P, Brodmann M, Lang W, et al. Periprocedual management of vitamin K antagonist\u2019s with low molecular weight heparins during invasive procedures\u2013consensus of experts. Wien Klin Wochenschr. 2013;125(13\u201314):412\u201320.","journal-title":"Wien Klin Wochenschr"},{"issue":"3","key":"653_CR184","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1097\/ACO.0000000000000875","volume":"33","author":"DC Filipescu","year":"2020","unstructured":"Filipescu DC, Stefan MG, Valeanu L, Popescu WM. Perioperative management of antiplatelet therapy in noncardiac surgery. Curr Opin Anaesthesiol. 2020;33(3):454\u201362.","journal-title":"Curr Opin Anaesthesiol"},{"issue":"1","key":"653_CR185","doi-asserted-by":"publisher","first-page":"38","DOI":"10.6001\/actamedica.v26i1.3954","volume":"26","author":"M Blake","year":"2019","unstructured":"Blake M, Roadley-Battin R, Torlinski T. Prophylactic anti-coagulation after severe burn injury in critical care settings. Acta Med Lituan. 2019;26(1):38\u201345.","journal-title":"Acta Med Lituan"},{"issue":"2 Suppl","key":"653_CR186","doi-asserted-by":"publisher","first-page":"e326S","DOI":"10.1378\/chest.11-2298","volume":"141","author":"JD Douketis","year":"2012","unstructured":"Douketis JD, Spyropoulos AC, Spencer FA, Mayr M, Jaffer AK, Eckman MH, et al. Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e326S\u2013e350.","journal-title":"Chest"},{"issue":"1","key":"653_CR187","volume":"10","author":"N Li","year":"2023","unstructured":"Li N, Wang L, Li L, Yang MZ, Wang QX, Bai XW, et al. The correlation between gut microbiome and atrial fibrillation: pathophysiology and therapeutic perspectives. Mil Med Res. 2023;10(1):51.","journal-title":"Mil Med Res"},{"issue":"4","key":"653_CR188","volume":"6","author":"SA Kustos","year":"2019","unstructured":"Kustos SA, Fasinu PS. Direct-acting oral anticoagulants and their reversal agents-an update. Medicines (Basel). 2019;6(4):103.","journal-title":"Medicines (Basel)"},{"issue":"2","key":"653_CR189","first-page":"111","volume":"12","author":"T Ciurus","year":"2015","unstructured":"Ciurus T, Sobczak S, Cichocka-Radwan A, Lelonek M. New oral anticoagulants - a practical guide. Kardiochir Torakochirurgia Pol. 2015;12(2):111\u20138.","journal-title":"Kardiochir Torakochirurgia Pol"},{"issue":"1","key":"653_CR190","doi-asserted-by":"publisher","first-page":"20356","DOI":"10.1038\/s41598-019-56887-w","volume":"9","author":"JM Kang","year":"2019","unstructured":"Kang JM, Park KH, Ahn S, Cho S, Han A, Lee T, et al. Rivaroxaban after thrombolysis in acute iliofemoral venous thrombosis: a randomized, open-labeled, multicenter trial. Sci Rep. 2019;9(1):20356.","journal-title":"Sci Rep"},{"issue":"6","key":"653_CR191","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1160\/TH15-09-0756","volume":"115","author":"GE Raskob","year":"2016","unstructured":"Raskob GE, Spyropoulos AC, Zrubek J, Ageno W, Albers G, Elliott CG, et al. The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE. Design, rationale, and clinical implications. Thromb Haemost. 2016;115(6):1240\u20138.","journal-title":"Thromb Haemost"},{"issue":"4","key":"653_CR192","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1177\/1060028019886092","volume":"54","author":"IJ Perales","year":"2020","unstructured":"Perales IJ, San Agustin K, Deangelo J, Campbell AM. Rivaroxaban versus warfarin for stroke prevention and venous thromboembolism treatment in extreme obesity and high body weight. Ann Pharmacother. 2020;54(4):344\u201350.","journal-title":"Ann Pharmacother"},{"issue":"1","key":"653_CR193","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-023-03069-1","volume":"21","author":"D Yoon","year":"2023","unstructured":"Yoon D, Jeong HE, Park S, You SC, Bang SM, Shin JY. Real-world data emulating randomized controlled trials of non-vitamin K antagonist oral anticoagulants in patients with venous thromboembolism. BMC Med. 2023;21(1):375.","journal-title":"BMC Med"},{"issue":"3","key":"653_CR194","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/jcph.5","volume":"53","author":"D Kubitza","year":"2013","unstructured":"Kubitza D, Becka M, Roth A, Mueck W. The influence of age and gender on the pharmacokinetics and pharmacodynamics of rivaroxaban\u2013an oral, direct factor Xa inhibitor. J Clin Pharmacol. 2013;53(3):249\u201355.","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"653_CR195","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40262-013-0100-7","volume":"53","author":"W Mueck","year":"2014","unstructured":"Mueck W, Stampfuss J, Kubitza D, Becka M. Clinical pharmacokinetic and pharmacodynamic profile of rivaroxaban. Clin Pharmacokinet. 2014;53(1):1\u201316.","journal-title":"Clin Pharmacokinet"},{"issue":"19","key":"653_CR196","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1016\/j.jacc.2018.03.023","volume":"71","author":"A Qamar","year":"2018","unstructured":"Qamar A, Vaduganathan M, Greenberger NJ, Giugliano RP. Oral anticoagulation in patients with liver disease. J Am Coll Cardiol. 2018;71(19):2162\u201375.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"653_CR197","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3390\/medicina59020346","volume":"59","author":"RS Costache","year":"2023","unstructured":"Costache RS, Dragomirica AS, Gheorghe BE, Balaban VD, Stanciu SM, Jinga M, et al. Oral anticoagulation in patients with chronic liver disease. Medicina (Kaunas). 2023;59(2):346.","journal-title":"Medicina (Kaunas)"},{"issue":"12","key":"653_CR198","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","volume":"361","author":"SJ Connolly","year":"2009","unstructured":"Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361(12):1139\u201351.","journal-title":"N Engl J Med"},{"issue":"22","key":"653_CR199","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1093\/eurheartj\/ehr113","volume":"32","author":"J Oldgren","year":"2011","unstructured":"Oldgren J, Budaj A, Granger CB, Khder Y, Roberts J, Siegbahn A, et al. Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial. Eur Heart J. 2011;32(22):2781\u20139.","journal-title":"Eur Heart J"},{"issue":"9745","key":"653_CR200","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/S0140-6736(10)61194-4","volume":"376","author":"L Wallentin","year":"2010","unstructured":"Wallentin L, Yusuf S, Ezekowitz MD, Alings M, Flather M, Franzosi MG, et al. Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial. Lancet. 2010;376(9745):975\u201383.","journal-title":"Lancet"},{"issue":"3","key":"653_CR201","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.thromres.2011.12.014","volume":"129","author":"C Becattini","year":"2012","unstructured":"Becattini C, Vedovati MC, Agnelli G. Old and new oral anticoagulants for venous thromboembolism and atrial fibrillation: a review of the literature. Thromb Res. 2012;129(3):392\u2013400.","journal-title":"Thromb Res"},{"issue":"9","key":"653_CR202","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1056\/NEJMoa1007432","volume":"364","author":"SJ Connolly","year":"2011","unstructured":"Connolly SJ, Eikelboom J, Joyner C, Diener HC, Hart R, Golitsyn S, et al. Apixaban in patients with atrial fibrillation. N Engl J Med. 2011;364(9):806\u201317.","journal-title":"N Engl J Med"},{"issue":"4","key":"653_CR203","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1097\/TA.0000000000001189","volume":"81","author":"AA Maung","year":"2016","unstructured":"Maung AA, Bhattacharya B, Schuster KM, Davis KA. Trauma patients on new oral anticoagulation agents have lower mortality than those on warfarin. J Trauma Acute Care Surg. 2016;81(4):652\u20137.","journal-title":"J Trauma Acute Care Surg"},{"issue":"9","key":"653_CR204","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1182\/blood.2021014835","volume":"142","author":"IJ Akpan","year":"2023","unstructured":"Akpan IJ, Hunt BJ. How i approach the prevention and treatment of thrombotic complications in hospitalized patients. Blood. 2023;142(9):769\u201376.","journal-title":"Blood"},{"issue":"9025","key":"653_CR205","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S0140-6736(96)01109-9","volume":"348","author":"G Palareti","year":"1996","unstructured":"Palareti G, Leali N, Coccheri S, Poggi M, Manotti C, D\u2019Angelo A, et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet. 1996;348(9025):423\u20138.","journal-title":"Lancet"},{"issue":"3","key":"653_CR206","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/s11239-022-02665-x","volume":"54","author":"Y Yamashita","year":"2022","unstructured":"Yamashita Y, Morimoto T, Klok FA, Barco S, Nishimoto Y, Kato T, et al. Anticoagulation strategies and clinical outcomes after bleeding events during anticoagulation therapy for venous thromboembolism in the practice-based Japanese registry. J Thromb Thrombolysis. 2022;54(3):524\u201334.","journal-title":"J Thromb Thrombolysis"},{"issue":"1","key":"653_CR207","volume":"10","author":"SY Liu","year":"2023","unstructured":"Liu SY, Xu SY, Yin L, Yang T, Jin K, Zhang QB, et al. Management of regional citrate anticoagulation for continuous renal replacement therapy: guideline recommendations from Chinese emergency medical doctor consensus. Mil Med Res. 2023;10(1):23.","journal-title":"Mil Med Res"},{"issue":"7","key":"653_CR208","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1055\/a-1690-8728","volume":"122","author":"F Khan","year":"2022","unstructured":"Khan F, Rahman A, Tritschler T, Carrier M, Kearon C, Weitz JI, et al. Long-term risk of major bleeding after discontinuing anticoagulation for unprovoked venous thromboembolism: a systematic review and meta-analysis. Thromb Haemost. 2022;122(7):1186\u201397.","journal-title":"Thromb Haemost"},{"issue":"5","key":"653_CR209","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.thromres.2005.04.010","volume":"117","author":"AB Holley","year":"2006","unstructured":"Holley AB, Moores LK, Jackson JL. Provider preferences for DVT prophylaxis. Thromb Res. 2006;117(5):563\u20138.","journal-title":"Thromb Res"},{"issue":"10","key":"653_CR210","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1097\/ACM.0b013e3182a4aa51","volume":"88","author":"SK Pingleton","year":"2013","unstructured":"Pingleton SK, Carlton E, Wilkinson S, Beasley J, King T, Wittkopp C, et al. Reduction of venous thromboembolism (VTE) in hospitalized patients: aligning continuing education with interprofessional team-based quality improvement in an academic medical center. Acad Med. 2013;88(10):1454\u20139.","journal-title":"Acad Med"},{"issue":"1","key":"653_CR211","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.1741-6787.2010.00209.x","volume":"8","author":"J Duff","year":"2011","unstructured":"Duff J, Walker K. Translating venous thromboembolism (VTE) prevention evidence into practice: a multidisciplinary evidence implementation project. Worldviews Evid Based Nurs. 2011;8(1):30\u20139.","journal-title":"Worldviews Evid Based Nurs"},{"issue":"4","key":"653_CR212","volume":"4","author":"SR Kahn","year":"2018","unstructured":"Kahn SR, Morrison DR, Diendere G, Piche A, Filion KB, Klil-Drori AJ, et al. Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism. Cochrane Database Syst Rev. 2018;4(4):CD008201.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"653_CR213","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/BCR.0000000000000088","volume":"35","author":"K Foster","year":"2014","unstructured":"Foster K. Clinical guidelines in the management of burn injury: a review and recommendations from the organization and delivery of burn care committee. J Burn Care Res. 2014;35(4):271\u201383.","journal-title":"J Burn Care Res"},{"issue":"2","key":"653_CR214","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2017-000653","volume":"4","author":"HR Rowswell","year":"2017","unstructured":"Rowswell HR, Nokes TJC. Significant reduction in hospital-acquired thrombosis: impact of national risk assessment and real-time feedback. Open Heart. 2017;4(2):e000653.","journal-title":"Open Heart"},{"key":"653_CR215","unstructured":"Quality Indicator User Guide: Patient Safety Indicators (PSI) Composite Measures, v2022. https:\/\/qualityindicators.ahrq.gov\/Downloads\/Modules\/PSI\/V2022\/PSI_Composite_Measures.pdf. Accessed 1 June 2022."},{"key":"653_CR216","unstructured":"Medical Quality Management and Control Indicators for Tertiary General Hospitals (2011 Edition). https:\/\/www.gov.cn\/govweb\/gzdt\/att\/att\/site1\/20110127\/00142235eb180eab016801.doc. Accessed 14 Jan 2021"},{"key":"653_CR217","unstructured":"National Medical Quality and Safety Improvement Goals for 2021. https:\/\/www.gov.cn\/zhengce\/zhengceku\/2021-02\/22\/5588240\/files\/7f3670bbe56d4eb2a30c591."}],"container-title":["Military Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40779-025-00653-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40779-025-00653-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40779-025-00653-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T20:53:13Z","timestamp":1772830393000},"score":1,"resource":{"primary":{"URL":"https:\/\/mmrjournal.biomedcentral.com\/articles\/10.1186\/s40779-025-00653-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,2]]},"references-count":217,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["653"],"URL":"https:\/\/doi.org\/10.1186\/s40779-025-00653-9","relation":{},"ISSN":["2054-9369"],"issn-type":[{"value":"2054-9369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,2]]},"assertion":[{"value":"1 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"74"}}